JESSICA REESE: Open Payments
NPI 1841955986 · DENISON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$278 in 14 payments from 7 companies in 2025. Trend: 2023 $248 · 2024 $156 · 2025 $278
Food & beverage: $278
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 6 | $126 |
| Astellas Pharma US Inc | 3 | $51 |
| PFIZER INC. | 1 | $26 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $22 |
| Organon LLC | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Exeltis, USA Inc. | 1 | $14 |
Products named: ZURZUVAE, Veozah, ABRYSVO, NEXPLANON, Qelbree, SLYND.
Industry payments across TX — which companies pay providers there.
